Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 13:36 PM 2012  
PLCM PLT EDCI DCMT CSRH 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for JNJ and SNY ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Johnson & Johnson  and   SanofiAventis
Check Correlation Matrix  
Daily Returns (%)
JNJ  SNY  
Timeline
Considering 30-days investment horizon, Johnson & Johnson is expected to generate 0.32 times more return on investment than SanofiAventis. However, Johnson & Johnson is 3.09 times less risky than SanofiAventis. It trades about -0.36 of its potential returns per unit of risk. SanofiAventis is currently generating about -0.31 per unit of risk. If you would invest 6,484 in Johnson & Johnson on April 26, 2012 and sell it today you would lose (233.00) from holding Johnson & Johnson or give up 3.59% of portfolio value over 30 days.

Diversification

Modest diversification
Overlapping area represents amount of risk that can be diversified away by holding Johnson & Johnson and SanofiAventis in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.25
 Parameters
Time Period1 Month [change]
DirectionPositive SNY Moved Up vs JNJ
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between JNJ and SNY with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between JNJ and SNY to your reader
 
Get social with Correlation between JNJ and SNY
 Share Correlation between JNJ and SNY 
Share Share Correlation between JNJ and SNY
    
    
 
       
Predicted Return Density
Expected Daily Returns   
JNJ  SNY  

Johnson & Johnson

 
    
    
Johnson
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Johnson & Johnson has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Pfizer Inc. vs. Johnson & Johnson
Novartis AG vs. Johnson & Johnson
Merck & Inc. vs. Johnson & Johnson
GlaxoSmithKline plc vs. Johnson & Johnson
Abbott Laboratories vs. Johnson & Johnson
SanofiAventis vs. Johnson & Johnson
  

SanofiAventis

 
    
    
SanofiAventis
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days SanofiAventis has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Johnson & Johnson vs. SanofiAventis
Pfizer Inc. vs. SanofiAventis
Novartis AG vs. SanofiAventis
Merck & Inc. vs. SanofiAventis
GlaxoSmithKline plc vs. SanofiAventis
Abbott Laboratories vs. SanofiAventis
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting